Thermogenesis Holdings Inc
ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics in the United States, China, the United Arab Emirates, Vietnam, and internationally. The company provides medical device products for automated cell processing. Its clinical bio-banking applications include AXP II Automated Cell Separa… Read more
Thermogenesis Holdings Inc (THMO) - Net Assets
Latest net assets as of March 2024: $-1.09 Million USD
Based on the latest financial reports, Thermogenesis Holdings Inc (THMO) has net assets worth $-1.09 Million USD as of March 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($10.09 Million) and total liabilities ($11.17 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-1.09 Million |
| % of Total Assets | -10.78% |
| Annual Growth Rate | N/A |
| 5-Year Change | -491.27% |
| 10-Year Change | -107.36% |
| Growth Volatility | 118.21 |
Thermogenesis Holdings Inc - Net Assets Trend (1986–2023)
This chart illustrates how Thermogenesis Holdings Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Thermogenesis Holdings Inc (1986–2023)
The table below shows the annual net assets of Thermogenesis Holdings Inc from 1986 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | $-3.58 Million | -207.85% |
| 2022-12-31 | $3.32 Million | -2.18% |
| 2021-12-31 | $3.40 Million | -42.13% |
| 2020-12-31 | $5.87 Million | +540.83% |
| 2019-12-31 | $916.00K | -86.39% |
| 2018-12-31 | $6.73 Million | -78.17% |
| 2017-12-31 | $30.84 Million | -4.45% |
| 2016-12-31 | $32.27 Million | -7.53% |
| 2015-12-31 | $34.90 Million | -28.33% |
| 2014-12-31 | $48.70 Million | +265.66% |
| 2013-12-31 | $13.32 Million | -16.23% |
| 2012-12-31 | $15.90 Million | -20.88% |
| 2011-12-31 | $20.09 Million | +13.02% |
| 2010-12-31 | $17.78 Million | -20.82% |
| 2009-12-31 | $22.45 Million | -26.44% |
| 2008-12-31 | $30.52 Million | -19.27% |
| 2007-12-31 | $37.81 Million | -9.91% |
| 2006-12-31 | $41.97 Million | +199.14% |
| 2005-12-31 | $14.03 Million | -33.08% |
| 2004-12-31 | $20.97 Million | +98.30% |
| 2003-12-31 | $10.57 Million | +3.74% |
| 2002-12-31 | $10.19 Million | +28.50% |
| 2001-12-31 | $7.93 Million | +39.35% |
| 2000-12-31 | $5.69 Million | -15.04% |
| 1999-12-31 | $6.70 Million | +19.64% |
| 1998-12-31 | $5.60 Million | -30.00% |
| 1997-12-31 | $8.00 Million | +81.82% |
| 1996-12-31 | $4.40 Million | 0.00% |
| 1995-12-31 | $4.40 Million | +120.00% |
| 1994-12-31 | $2.00 Million | -4.76% |
| 1993-12-31 | $2.10 Million | +5.00% |
| 1992-12-31 | $2.00 Million | +25.00% |
| 1991-12-31 | $1.60 Million | +14.29% |
| 1990-12-31 | $1.40 Million | +180.00% |
| 1989-12-31 | $500.00K | -16.67% |
| 1988-12-31 | $600.00K | -40.00% |
| 1987-12-31 | $1.00 Million | -47.37% |
| 1986-12-31 | $1.90 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Thermogenesis Holdings Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 28326800000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $4.00K | % |
| Other Comprehensive Income | $114.00K | % |
| Other Components | $282.38 Million | % |
| Total Equity | $-1.67 Million | 100.00% |
Thermogenesis Holdings Inc Competitors by Market Cap
The table below lists competitors of Thermogenesis Holdings Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Cosco Capital Inc
PSE:COSCO
|
$1.06K |
|
Reko International Group Inc
PINK:RKIGF
|
$1.06K |
|
Wilcon Depot Inc
PSE:WLCON
|
$1.06K |
|
Olympia Spinning and Weaving Mills Ltd
KAR:OML
|
$1.06K |
|
REX INTERNATIONAL (RXI.SG)
STU:RXI
|
$1.06K |
|
Arc Minerals Limited
LSE:ARCM
|
$1.06K |
|
The Organic Meat
KAR:TOMCL
|
$1.06K |
|
Ikigai Ventures Ltd
LSE:IKIV
|
$1.06K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Thermogenesis Holdings Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 4,296,000 to -1,667,000, a change of -5,963,000 (-138.8%).
- Net loss of 17,975,000 reduced equity.
- New share issuances of 4,186,000 increased equity.
- Other comprehensive income increased equity by 3,000.
- Other factors increased equity by 7,823,000.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-17.98 Million | -1078.28% |
| Share Issuances | $4.19 Million | +251.11% |
| Other Comprehensive Income | $3.00K | +0.18% |
| Other Changes | $7.82 Million | +469.29% |
| Total Change | $- | -138.80% |
Book Value vs Market Value Analysis
This analysis compares Thermogenesis Holdings Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1986-12-31 | $15833.33 | $0.00 | x |
| 1987-12-31 | $7518.80 | $0.00 | x |
| 1988-12-31 | $4477.61 | $0.00 | x |
| 1989-12-31 | $2906.98 | $0.00 | x |
| 1990-12-31 | $6392.69 | $0.00 | x |
| 1991-12-31 | $6477.73 | $0.00 | x |
| 1992-12-31 | $7782.10 | $0.00 | x |
| 1993-12-31 | $7446.81 | $0.00 | x |
| 1994-12-31 | $5665.72 | $0.00 | x |
| 1995-12-31 | $13785.32 | $0.00 | x |
| 1996-12-31 | $12464.59 | $0.00 | x |
| 1997-12-31 | $18181.82 | $0.00 | x |
| 1998-12-31 | $10666.67 | $0.00 | x |
| 1999-12-31 | $11713.29 | $0.00 | x |
| 2000-12-31 | $8261.25 | $0.00 | x |
| 2001-12-31 | $8983.01 | $0.00 | x |
| 2002-12-31 | $10422.29 | $0.00 | x |
| 2003-12-31 | $10407.48 | $0.00 | x |
| 2004-12-31 | $18075.86 | $0.00 | x |
| 2005-12-31 | $11126.88 | $0.00 | x |
| 2006-12-31 | $30480.76 | $0.00 | x |
| 2007-12-31 | $24681.46 | $0.00 | x |
| 2008-12-31 | $19718.99 | $0.00 | x |
| 2009-12-31 | $14430.59 | $0.00 | x |
| 2010-12-31 | $11411.42 | $0.00 | x |
| 2011-12-31 | $12207.17 | $0.00 | x |
| 2012-12-31 | $8730.37 | $0.00 | x |
| 2013-12-31 | $7253.81 | $0.00 | x |
| 2014-12-31 | $18089.90 | $0.00 | x |
| 2015-12-31 | $7785.41 | $0.00 | x |
| 2016-12-31 | $4824.07 | $0.00 | x |
| 2017-12-31 | $1399.46 | $0.00 | x |
| 2018-12-31 | $206.47 | $0.00 | x |
| 2019-12-31 | $6.14 | $0.00 | x |
| 2020-12-31 | $41.57 | $0.00 | x |
| 2021-12-31 | $14.60 | $0.00 | x |
| 2022-12-31 | $7.80 | $0.00 | x |
| 2023-12-31 | $-0.70 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Thermogenesis Holdings Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -190.31%
- • Asset Turnover: 0.84x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-147.61%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1986 | -42.11% | -800.00% | 0.05x | 1.16x | $-990.00K |
| 1987 | -110.00% | -220.00% | 0.38x | 1.30x | $-1.20 Million |
| 1988 | -83.33% | -41.67% | 1.09x | 1.83x | $-560.00K |
| 1989 | -160.00% | -72.73% | 0.58x | 3.80x | $-850.00K |
| 1990 | -50.00% | -38.89% | 0.95x | 1.36x | $-840.00K |
| 1991 | -93.75% | -83.33% | 0.82x | 1.38x | $-1.66 Million |
| 1992 | -15.00% | -15.00% | 0.87x | 1.15x | $-500.00K |
| 1994 | -5.00% | -3.03% | 1.22x | 1.35x | $-300.00K |
| 1995 | -13.64% | -14.63% | 0.69x | 1.34x | $-1.04 Million |
| 1996 | -13.64% | -14.63% | 0.69x | 1.34x | $-1.04 Million |
| 1997 | -60.00% | -72.73% | 0.65x | 1.28x | $-5.60 Million |
| 1998 | -171.43% | -213.33% | 0.58x | 1.39x | $-10.16 Million |
| 1999 | -91.04% | -119.61% | 0.63x | 1.21x | $-6.77 Million |
| 2000 | -102.21% | -138.16% | 0.63x | 1.18x | $-6.39 Million |
| 2001 | -84.88% | -116.25% | 0.61x | 1.20x | $-7.53 Million |
| 2002 | -49.43% | -52.76% | 0.78x | 1.20x | $-6.06 Million |
| 2003 | -52.99% | -55.00% | 0.80x | 1.21x | $-6.66 Million |
| 2004 | -22.78% | -41.02% | 0.48x | 1.15x | $-6.87 Million |
| 2005 | -58.58% | -80.77% | 0.58x | 1.24x | $-9.62 Million |
| 2006 | -14.63% | -50.98% | 0.25x | 1.13x | $-10.34 Million |
| 2007 | -17.92% | -40.45% | 0.38x | 1.16x | $-10.56 Million |
| 2008 | -30.08% | -41.83% | 0.57x | 1.25x | $-12.23 Million |
| 2009 | -38.08% | -43.18% | 0.72x | 1.23x | $-10.80 Million |
| 2010 | -29.21% | -22.49% | 0.96x | 1.35x | $-6.97 Million |
| 2011 | -12.78% | -10.97% | 0.96x | 1.21x | $-4.58 Million |
| 2012 | -31.36% | -26.21% | 0.90x | 1.33x | $-6.58 Million |
| 2013 | -23.17% | -17.18% | 0.97x | 1.39x | $-4.42 Million |
| 2014 | -17.72% | -53.99% | 0.25x | 1.29x | $-13.50 Million |
| 2015 | -42.55% | -92.58% | 0.32x | 1.45x | $-18.34 Million |
| 2016 | -57.60% | -155.82% | 0.24x | 1.55x | $-21.82 Million |
| 2017 | -94.35% | -200.31% | 0.31x | 1.52x | $-32.18 Million |
| 2018 | -470.46% | -410.63% | 0.66x | 1.73x | $-40.56 Million |
| 2019 | -2460.36% | -72.79% | 0.86x | 39.41x | $-9.54 Million |
| 2020 | -281.91% | -167.81% | 0.47x | 3.60x | $-16.93 Million |
| 2021 | -297.26% | -122.43% | 0.45x | 5.39x | $-11.76 Million |
| 2022 | -262.34% | -107.51% | 0.54x | 4.51x | $-11.70 Million |
| 2023 | 0.00% | -190.31% | 0.84x | 0.00x | $-17.81 Million |
Industry Comparison
This section compares Thermogenesis Holdings Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Thermogenesis Holdings Inc (THMO) | $-1.09 Million | -42.11% | N/A | $1.06K |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |